SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-05-004558
Filing Date
2005-05-10
Accepted
2005-05-10 14:54:21
Documents
6
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS 10-Q d63754_10-q.htm 10-Q 198792
2 ARIAD PHARMACEUTICALS EXHIBIT 10.1 d63754_ex10-1.htm EX-10.1 229726
3 ARIAD PHARMACEUTICALS EXHIBIT 10.2 d63754_ex10-2.htm EX-10.2 96168
4 ARIAD PHARMACEUTICALS EXHIBIT 31.1 d63754_ex31-1.htm EX-31.1 9483
5 ARIAD PHARMACEUTICALS EXHIBIT 31.2 d63754_ex31-2.htm EX-31.2 9448
6 ARIAD PHARMACEUTICALS EXHIBIT 32.1 d63754_ex32-1.htm EX-32.1 4785
  Complete submission text file 0001157523-05-004558.txt   549799
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 05815939
SIC: 2836 Biological Products, (No Diagnostic Substances)